|

G-CSF Clinical Trials

11 actively recruiting trials across 6 locations

Also known as: Filgrastim, Granulocyte Colony Stimulating Factor, Granulocyte colony-stimulating factor, Neupogen, Granix, Zarxio, Filgrastim, filgrastim, granulocyte, neupogen

Other5 trials

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Phase 3
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Phase 3
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
Phase 3
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
Phase 2/3
VHAG in Treating R/R T-ALL/LBL
Phase 2

Birmingham, Alabama1 trial

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

University of Alabama at Birmingham

Phase 1

Minneapolis, Minnesota1 trial

Auto Stem Cell Transplant for Lymphoma Patients

Masonic Cancer Center, University of Minnesota

Phase 2

New York, New York1 trial

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Memorial Sloan Kettering Cancer Center

Phase 2

Pittsburgh, Pennsylvania1 trial

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

UPMC Presbyterian

Phase 1/2

Memphis, Tennessee1 trial

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

St. Jude Children's Research Hospital

Phase 2

Houston, Texas1 trial

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.